Deoxycholic acid Subcutaneous and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
Determining the interaction of Deoxycholic acid Subcutaneous and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deoxycholic acid
Brand name: Kybella
Synonyms: Deoxycholic acid, Deoxycholic Acid
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deoxycholic acid Subcutaneous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Deoxycholic acid Subcutaneous-Kitabis Pak
- Deoxycholic acid Subcutaneous-Kitabis Pak inhalation
- Deoxycholic acid Subcutaneous-Klofensaid II
- Deoxycholic acid Subcutaneous-Klonopin
- Deoxycholic acid Subcutaneous-Klonopin Wafer
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Depacon
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Depade
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Depakene
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Depakene (Valproic Acid Capsules)
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Depakene (Valproic Acid Liquid)
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Depakote